Heterogeneity of neuroblastoma cell lines in insulin‐like growth factor 1 receptor/Akt pathway‐mediated cell proliferative responses

Insulin‐like growth factor 1 receptor (IGF‐1R) is critical for cancer cell proliferation; however, recent clinical anti‐IGF‐1R trials did not show clear clinical benefit in cancer therapy. We hypothesized that IGF‐1R signaling‐mediated proliferative response is heterogeneous in neuroblastoma (NB) ce...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Sci
Asıl Yazarlar: Qi, Lei, Toyoda, Hidemi, Shankar, Vipin, Sakurai, Naoto, Amano, Keishirou, Kihira, Kentaro, Iwasa, Tadashi, Deguchi, Takao, Hori, Hiroki, Azuma, Eiichi, Gabazza, Esteban C., Komada, Yoshihiro
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2013
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7656538/
https://ncbi.nlm.nih.gov/pubmed/23710710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12204
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller